Navigation Links
Asymmetrex's AlphaSTEM Test Adult Tissue Stem Cell Counting Technology Established to Be a Leading Interest for Regenerative Medicine in 2016
Date:1/10/2017

At the end of 2015, James Sherley, M.D., Ph.D., founder and director of Asymmetrex, made a decision to enlist RegMedNet as a partner in beginning the targeted introduction of the company’s new technology for counting adult tissue stem cells to stem cell research and stem cell medicine communities internationally. RegMedNet’s focus on accelerating progress in the field of regenerative medicine promised to engage a particularly relevant community of future users of the new technology.

In early 2016, the new partnership produced a series of scientific perspectives that illuminated the long-standing need for a means to count adult tissue stem cells in several varied research and medical disciplines. These included applications needed in stem cell transplantation medicine, regenerative medicine clinical trials, drug development, and general stem cell research. The unique series of perspectives, which highlighted the scientific, medical, and clinical potential precluded for more than half a century by the inability to count tissue stem cells was followed by a webinar describing Asymmetrex’s new solution to the counting problem.

It is gratifying, to say the least, that RegMedNet visitors showed such a high degree of interest in Asymmetrex’s new AlphaSTEM Test for counting adult tissue stem cells. Establishing that such an attraction exists in this particular international forum predicts that Asymmetrex’s new contract service for specific counting and monitoring of stem cells from many different human tissues, launched in September 2016, will continue to build its client base in 2017. The company will continue to partner with RegMedNet for this purpose.

Asymmetrex Director Sherley says that he is putting the RegMedNet partnership among his good decisions for the growth and development of Asymmetrex. However, he adds, “Surely, though, this is only the first indication of the tremendous awareness of what Asymmetrex has accomplished that will follow.”

About Asymmetrex
Asymmetrex, LLC is a Massachusetts life sciences company with a focus on developing technologies to advance stem cell medicine. Asymmetrex’s founder and director, James L. Sherley, M.D., Ph.D. is an internationally recognized expert on the unique properties of adult tissue stem cells. The company’s patent portfolio contains biotechnologies that solve the two main technical problems – production and quantification – that have stood in the way of successful commercialization of human adult tissue stem cells for regenerative medicine and drug development. In addition, the portfolio includes novel technologies for isolating cancer stem cells and producing induced pluripotent stem cells for disease research purposes. Currently, Asymmetrex’s focus is employing its technological advantages to develop and market facile methods for monitoring adult stem cell number and function in stem cell transplantation treatments and in pre-clinical assays for drug safety.

Read the full story at http://www.prweb.com/releases/2017/01/prweb13970410.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. In a Scheduled March 22 RegMedNet Webinar, Asymmetrex Discusses the Strategy for Its AlphaSTEM Technology for Counting Adult Tissue Stem Cells
2. CHMP Recommends Approval of Lillys Baricitinib for the Treatment of Adults with Moderate to Severe Active Rheumatoid Arthritis (RA)
3. Designed by RoosterBio Inc.: New Xeno-free Cell Culture Media Product Developed to Accelerate Manufacturing and Commercialization of Adult Stem Cell Products
4. MedRebels Educates on the Benefits of Regenerative Adult Stem Cell Therapy
5. SFARI Launches SPARK, Nations Largest Research Initiative for Parents, Children and Adults with Autism
6. CSL Behring sponsors IDF webinar series for young adults living with primary immunodeficiencies
7. In Upcoming Webinar and Conferences, Asymmetrex Will Intensify Education on Counting Adult Tissue Stem Cells For Regenerative Medicine and Drug Development
8. Nerium International’s Young Entrepreneur Program (YEP) Attracts Thousands of Young Adults Nationwide
9. U.S. FDA Acknowledges Receipt of Resubmission of Shires New Drug Application for Lifitegrast for Dry Eye Disease in Adults
10. Asymmetrex Supports UK RegMedNet with Sponsorship for Education on the Importance of Counting Adult Tissue Stem Cells in Regenerative Medicine Practice
11. Childhood Leukemias Forged by Different Evolutionary Forces than in Older Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... ... in its endogenous context, enabling overexpression experiments and avoiding the use of exogenous ... RNA guides is transformative for performing systematic gain-of-function studies. , This complement ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive ... a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... CALIFORNIA (PRWEB) , ... October 10, 2017 , ... ... technological innovation and business process optimization firm for the life sciences and healthcare ... BoxWorks conference in San Francisco. , The presentation, “Automating GxP Validation for ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
(Date:3/30/2017)... 30, 2017  On April 6-7, 2017, Sequencing.com will ... hackathon at Microsoft,s headquarters in ... focus on developing health and wellness apps that provide ... the Genome is the first hackathon for personal ... largest companies in the genomics, tech and health industries ...
(Date:3/29/2017)...  higi, the health IT company that operates the ... , today announced a Series B investment from ... The new investment and acquisition accelerates higi,s strategy to ... population health activities through the collection and workflow integration ... collects and secures data today on behalf of over ...
Breaking Biology News(10 mins):